Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
about
Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative DiseasesAcute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome.A proposed role for efflux transporters in the pathogenesis of hydrocephalusThe effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption.Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat.Biliary Elimination of Pemetrexed Is Dependent on Mrp2 in Rats: Potential Mechanism of Variable Response in Nonalcoholic Steatohepatitis.Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation.Translational gap in ongoing clinical trials for glioma.Activity of pemetrexed-based regimen as first-line chemotherapy for advanced non-small cell lung cancer with asymptomatic inoperable brain metastasis: a retrospective study.Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3.Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier
P2860
Q28829017-A4815FF9-B653-4E53-B829-84DA39D3C580Q30359285-F19B8CC3-75E7-443E-96FB-4495D2345444Q34147836-1EB674D1-6DC9-48A7-9C8F-66B2711B0051Q37663394-ED3E5E2E-4579-41D9-9CC0-48245FFE8EE8Q38207943-5EA58DC6-C7A4-4560-9786-CB9B312B228FQ38963604-E8FCFEFD-D904-4BAD-8CEC-0A373EEC84E6Q41068390-F7C6ECB6-674B-4F3F-AE31-137FA7281F32Q41711062-1324275D-0FB1-422D-B04F-E722E8E73701Q41814330-4CE927DC-B45F-4BB6-BB81-1E592D9C3C68Q46550033-1B2356A1-34EB-4785-90D6-433F2BA0C50BQ48002716-409A0A15-E47C-481B-A63C-0570DA5A288FQ48299342-2AAE89E6-707A-4AFC-B0A4-85A8BC9EEFFEQ53052634-14AF3806-85B9-4DBE-B9E5-D23DD98E603CQ57810063-2089E7CF-C50B-45F4-B08C-CE8676B3CC98
P2860
Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Brain efflux index to investig ...... f pemetrexed and methotrexate.
@en
type
label
Brain efflux index to investig ...... f pemetrexed and methotrexate.
@en
prefLabel
Brain efflux index to investig ...... f pemetrexed and methotrexate.
@en
P2093
P2860
P356
P1476
Brain efflux index to investig ...... f pemetrexed and methotrexate.
@en
P2093
Sagar Agarwal
William F Elmquist
P2860
P304
P356
10.1124/DMD.112.049254
P577
2013-01-07T00:00:00Z